TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16291601

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 2859

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) with clopidogrel and standard fibrinolytic and aspirin
Number of subjects: 2859
Study: 11858203

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide in sterile saline
Number of subjects: 43

Group type: COMPARATOR
Intervention: Gutta-percha and AH-26 sealer
Number of subjects: 43
Study: 9526191

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 0
Study: 7725867

Group type: EXPERIMENTAL
Intervention: Meperidine 0.5 mg/kg with epinephrine (14 patients)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Meperidine 0.5 mg/kg without epinephrine (16 patients)
Number of subjects: 30
Study: 2639069

Group type: EXPERIMENTAL
Intervention: Chlorhexidine 0.1% mouth rinse for 2 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physiological saline solution mouth rinse
Number of subjects: 0
Study: 823563

Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28386788

Group type: EXPERIMENTAL
Intervention: High-load AECT
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Low-load AECT
Number of subjects: 23

Group type: COMPARATOR
Intervention: Compression-only therapy (CT)
Number of subjects: 23
Study: 27413670

Group type: EXPERIMENTAL
Intervention: ADAPT program (technology-assisted goal setting)
Number of subjects: 54
Study: 25271534

Group type: EXPERIMENTAL
Intervention: Mitomycin-C (MMC) applied using otowick
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Mitomycin-C (MMC) applied using cottonoids
Number of subjects: 47

Group type: COMPARATOR
Intervention: Normal saline applied using otowick
Number of subjects: 47

Group type: COMPARATOR
Intervention: Normal saline applied using cottonoids
Number of subjects: 47
Study: 22916209

Group type: EXPERIMENTAL
Intervention: MUP-CHX (n=210)
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: MUP-CHX in cardiothoracic patients (n=280)
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: MUP-CHX in orthopaedic patients (n=135)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Placebo (n=205)
Number of subjects: 415
Study: 19443914

Group type: EXPERIMENTAL
Intervention: Proficiency based virtual reality simulator training in laparoscopic salpingectomy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard clinical education (controls)
Number of subjects: 24
Study: 17313717

Group type: EXPERIMENTAL
Intervention: Serum prohepcidin concentration in healthy men
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Serum prohepcidin concentration in hereditary haemochromatosis patients
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Serum prohepcidin concentration in pregnant women
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Iron absorption efficiency
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Serum prohepcidin concentration and serum ferritin relationship
Number of subjects: 187
Study: 15449742

Group type: EXPERIMENTAL
Intervention: Propofol (2-5 mg kg(‐1) h(‐1))
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Sevoflurane (1-2%)
Number of subjects: 22
Study: 11405491

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IP)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control
Number of subjects: 22
Study: 9754479

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 20 mg orally (dose 1) and 10 mg (dose 2)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Hydrocodone 10 mg plus acetaminophen 1,000 mg orally (both doses)
Number of subjects: 125
Study: 8313331

Group type: EXPERIMENTAL
Intervention: DAB486IL-2 at 0.2 mg/kg daily for 5 days
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: DAB486IL-2 at 0.075 mg/kg and 0.115 mg/kg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: DAB486IL-2
Number of subjects: 15
Study: 3416497

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MP) at doses of 0.1 and 0.33 mg/kg three times daily
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MP) at high dose
Number of subjects: 16
Study: 1960623

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cromolyn sodium
Number of subjects: 10
Study: 1070466

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus immunotherapy (BCG and irradiated allogeneic myeloblastic leukaemia cells)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus immunotherapy
Number of subjects: 52
Study: 31618328

Group type: EXPERIMENTAL
Intervention: Dimethyldiguanide combined with clomifene citrate
Number of subjects: 79

Group type: COMPARATOR
Intervention: Clomifene citrate alone
Number of subjects: 79
Study: 28741683

Group type: EXPERIMENTAL
Intervention: Novel oily emulsion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Methylcellulose
Number of subjects: 40

Group type: COMPARATOR
Intervention: Water
Number of subjects: 40
Study: 25042729

Group type: COMPARATOR
Intervention: Grid laser photocoagulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intravitreal ranibizumab (IVR) 0.5 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Combination of grid laser and IVR
Number of subjects: 30
Study: 23414646

Group type: EXPERIMENTAL
Intervention: Cognitive Intervention Program (CIP) for 6 months, 2 hours per session, twice per week.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 46
Study: 21195572

Group type: EXPERIMENTAL
Intervention: 550 mg iodine/(kg of LBW)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: 650 mg iodine/(kg of LBW)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: 750 mg iodine/(kg of LBW)
Number of subjects: 136

Group type: COMPARATOR
Intervention: 600 mg iodine/(kg of TBW)
Number of subjects: 136
Study: 19418859

Group type: EXPERIMENTAL
Intervention: Magic FoamCord (MFC) system
Number of subjects: 269

Group type: COMPARATOR
Intervention: Single cord retraction technique
Number of subjects: 269
Study: 17565936

Group type: EXPERIMENTAL
Intervention: Black cohosh
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 120
Study: 15087991

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 0
Study: 11843764

Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin (IVIG) treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Plasma exchange
Number of subjects: 12

Group type: COMPARATOR
Intervention: Comparison between IVIG and Plasma exchange
Number of subjects: 12
Study: 9738724

Group type: EXPERIMENTAL
Intervention: 3-day pulse course of dexamethasone
Number of subjects: 40

Group type: COMPARATOR
Intervention: 42-day course of dexamethasone
Number of subjects: 40
Study: 8113278

Group type: EXPERIMENTAL
Intervention: Foot orthosis
Number of subjects: 122

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 122
Study: 3177859

Group type: EXPERIMENTAL
Intervention: Cricoid pressure
Number of subjects: 40

Group type: COMPARATOR
Intervention: Stimulation of cricoid pressure
Number of subjects: 40
Study: 30257661

Group type: EXPERIMENTAL
Intervention: Breastfeeding education and support intervention (BFESI)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 432
Study: 27722974

Group type: EXPERIMENTAL
Intervention: COMMODITY12 mHealth system
Number of subjects: 60
Study: 23761871

Group type: EXPERIMENTAL
Intervention: micronized diosmin + hesperidin
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: aminaphthone
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: coumarin + troxerutin
Number of subjects: 136

Group type: COMPARATOR
Intervention: placebo (starch)
Number of subjects: 136
Study: 23084280

Group type: EXPERIMENTAL
Intervention: Integrated multi-component CVD risk reduction intervention
Number of subjects: 1146

Group type: COMPARATOR
Intervention: Usual care by physicians
Number of subjects: 1146
Study: 20157663

Group type: EXPERIMENTAL
Intervention: Quixfil (Xeno III)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Tetric Ceram (Syntac Classic)
Number of subjects: 43
Study: 17991697

Group type: EXPERIMENTAL
Intervention: Low-volume sprint interval training (SIT) - 4 to 6 repeats of a 30 s 'all out' Wingate Test, 3 days per week, mean power output approximately 500 W.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional endurance training (ET) - 40-60 min of continuous cycling at approximately 65% workload, 5 days per week, mean power output approximately 150 W.
Number of subjects: 20
Study: 16042771

Group type: EXPERIMENTAL
Intervention: Steroid-naïve asthmatic children
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Inhaled steroid-treated asthmatic children
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Steroid-treated asthmatic children
Number of subjects: 36
Study: 12125393

Group type: EXPERIMENTAL
Intervention: Electrodermal stimulation prior to presentation of word list
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electrodermal stimulation applied before word presentation in women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electrodermal stimulation applied after word presentation in men
Number of subjects: 0
Study: 10499179

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8694167

Group type: COMPARATOR
Intervention: Propofol alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propofol + Ephedrine 15 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propofol + Ephedrine 20 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propofol + Ephedrine 10 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 40
Study: 2004573

Group type: EXPERIMENTAL
Intervention: Anodyne‐Lubricant Jelly (ALJ) containing Dicaini, Lidocaine
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Anodyne‐Lubricant Jelly (ALJ) applied intracervically
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study: 6507998

Group type: EXPERIMENTAL
Intervention: Low-dose methylprednisolone (32 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (128 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29393137

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 530

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530
Study: 27875567

Group type: EXPERIMENTAL
Intervention: Confirming social influence condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Disconfirming social influence condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: No social influence condition
Number of subjects: 0
Study: 24841864

Group type: EXPERIMENTAL
Intervention: Guided Self-Change (GSC)
Number of subjects: 514

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 514
Study: 22486805

Group type: EXPERIMENTAL
Intervention: 5% sodium hypochlorite (NaOCl) with laser activation
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: 5% sodium hypochlorite (NaOCl) without laser activation
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Sterile bi-distilled water with laser activation
Number of subjects: 148

Group type: COMPARATOR
Intervention: Sterile bi-distilled water without laser activation
Number of subjects: 148
Study: 20375690

Group type: EXPERIMENTAL
Intervention: Revascularization and medical therapy
Number of subjects: 2146

Group type: COMPARATOR
Intervention: Medical therapy alone and deferred or no revascularization
Number of subjects: 2146

Group type: EXPERIMENTAL
Intervention: Glycemic control with insulin‐providing or insulin‐sensitizing drugs
Number of subjects: 2146

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 2146
Study: 18036421

Group type: EXPERIMENTAL
Intervention: Olopatadine nasal spray 0.2%
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Olopatadine nasal spray 0.4%
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Olopatadine nasal spray 0.6%
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 320
Study: 16094389

Group type: EXPERIMENTAL
Intervention: Assist/control with volume‐guarantee (AC+VG)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation with volume guarantee (SIMV+VG)
Number of subjects: 12
Study: 11880822

Group type: EXPERIMENTAL
Intervention: Water-based exercise (WEX) program, 12 weeks, 70 min per day, 3 days per week
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Water-based exercise (WEX) program
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 10429496

Group type: EXPERIMENTAL
Intervention: Provisc
Number of subjects: 60

Group type: COMPARATOR
Intervention: Healon GV
Number of subjects: 60
Study: 7481624

Group type: EXPERIMENTAL
Intervention: Dry lactulose (Duphalac Dry)
Number of subjects: 62
Study: 2210238

Group type: EXPERIMENTAL
Intervention: Multipolar electrocoagulation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Injection therapy with absolute ethanol
Number of subjects: 60
Study: 7192170

Group type: EXPERIMENTAL
Intervention: Counselling by a specialist nurse
Number of subjects: 152

Group type: COMPARATOR
Intervention: Care normally given by the surgical unit (Control)
Number of subjects: 152
Study: 31972599

Group type: EXPERIMENTAL
Intervention: Adjuvant capecitabine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gemcitabine and S‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gemcitabine, cisplatin and S‐1 (GCS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified FOLFOX (fluorouracil, leucovorin and oxaliplatin)
Number of subjects: 0
Study: 31301658

Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted transanal total mesorectal excision
Number of subjects: 6

Group type: COMPARATOR
Intervention: Laparoscopic total mesorectal excision
Number of subjects: 6
Study: 28102697

Group type: EXPERIMENTAL
Intervention: Goal-related implementation intentions (GI) delivered as text message reminders
Number of subjects: 8

Group type: COMPARATOR
Intervention: Educational review regarding goals (GR)
Number of subjects: 8
Study: 25867812

Group type: EXPERIMENTAL
Intervention: MTZ 30 mg/d for 42 days
Number of subjects: 22

Group type: COMPARATOR
Intervention: Low-iodine diet (LID)
Number of subjects: 22
Study: 23493674

Group type: EXPERIMENTAL
Intervention: SEPA (Salud, Educación, Prevención y Autocuidado) intervention
Number of subjects: 274
Study: 21346717

Group type: EXPERIMENTAL
Intervention: Breakfast diet
Number of subjects: 13

Group type: COMPARATOR
Intervention: Non-breakfast diet
Number of subjects: 13
Study: 19585653

Group type: EXPERIMENTAL
Intervention: Viramidine (VRD) 600 mg BID
Number of subjects: 972

Group type: COMPARATOR
Intervention: Ribavirin (RBV) weight-based (1000 or 1200 mg/day)
Number of subjects: 972
Study: 17391287

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 15539716

Group type: EXPERIMENTAL
Intervention: Zafirlukast 20 mg (Z20)
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Zafirlukast 160 mg (Z160)
Number of subjects: 641

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 641
Study: 11815725

Group type: EXPERIMENTAL
Intervention: Low dose testosterone (LDT) 62.5 mg/m2
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Conventional dose testosterone (CDT) 125 mg/m2
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Multiple dose testosterone (MDT) 62.5 mg/m2
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Low dose testosterone (LDT)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Conventional dose testosterone (CDT)
Number of subjects: 84
Study: 9893912

Group type: EXPERIMENTAL
Intervention: Investigational propofol emulsion (Group A 2nd anaesthesia)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control propofol emulsion (Group A 1st anaesthesia)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Investigational propofol emulsion (Group B 1st anaesthesia)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control propofol emulsion (Group B 2nd anaesthesia)
Number of subjects: 30
Study: 9431481

Group type: EXPERIMENTAL
Intervention: Acetylcholine or ergonovine maleate administration
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Spontaneous LAD spasms
Number of subjects: 45

Group type: COMPARATOR
Intervention: Spasm of the diagonal branch
Number of subjects: 45
Study: 1936695

Group type: EXPERIMENTAL
Intervention: Whole pancreas with bladder diversion
Number of subjects: 171

Group type: COMPARATOR
Intervention: Segmental pancreas transplantation
Number of subjects: 171
Study: 6814472

Group type: EXPERIMENTAL
Intervention: Ro 15-1788 (200 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Diazepam (40 mg)
Number of subjects: 6
Study: 30798474

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anodal tDCS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0
Study: 27512099

Group type: EXPERIMENTAL
Intervention: Water-based physiotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-water-based physiotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 30
Study: 25947649

Group type: EXPERIMENTAL
Intervention: Running CPET
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All CPETs
Number of subjects: 20
Study: 25163405

Group type: EXPERIMENTAL
Intervention: Epinastine 0.05% ophthalmic solution
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo ophthalmic solution
Number of subjects: 87

Group type: COMPARATOR
Intervention: Olopatadine 0.1% ophthalmic solution
Number of subjects: 87
Study: 22530938

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT) program, 8 weekly sessions of 2½ hours each.
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT) program
Number of subjects: 37
Study: 19393415

Group type: EXPERIMENTAL
Intervention: Tissue adhesive
Number of subjects: 72

Group type: COMPARATOR
Intervention: Surgical staples
Number of subjects: 72
Study: 17255745

Group type: EXPERIMENTAL
Intervention: Nevirapine
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Efavirenz
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Abacavir
Number of subjects: 460
Study: 15641876

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 11944589

Group type: EXPERIMENTAL
Intervention: Etizolam administered after hematoma removal
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (not given etizolam)
Number of subjects: 39
Study: 9483409

Group type: EXPERIMENTAL
Intervention: Eleutherococcus tincture for 20 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elton and Leveton for 20 days
Number of subjects: 0
Study: 8466023

Group type: EXPERIMENTAL
Intervention: A-3665 (0.25, 0.5, 1, 2, 4, 8, 16, 32, and 64 micrograms/kg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Alfentanil (4, 8, or 16 micrograms/kg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: A-3665 (16 micrograms/kg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: A-3665 (32 and 64 micrograms/kg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Alfentanil (32 and 64 micrograms/kg)
Number of subjects: 45
Study: 3768247

Group type: EXPERIMENTAL
Intervention: Cimetidine (1 g day‐1 for 7 days)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Ranitidine (300 mg day‐1 for 7 days)
Number of subjects: 6
Study: 31360702

Group type: EXPERIMENTAL
Intervention: Hypertensive subjects
Number of subjects: 10553

Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP)
Number of subjects: 10553

Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP)
Number of subjects: 10553

Group type: EXPERIMENTAL
Intervention: Hypertension (categorical variable)
Number of subjects: 10553
Study: 28675983

Group type: EXPERIMENTAL
Intervention: Intravenous fluid (IVF) supplementation (50 mL/kg over 8 hours)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Oral rehydration solution (ORS) (50 mL over 8 hours)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard therapy (control group)
Number of subjects: 150
Study: 26253748

Group type: EXPERIMENTAL
Intervention: MS Home Automated Telehealth (MS HAT) system
Number of subjects: 30

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 30
Study: 25457420

Group type: EXPERIMENTAL
Intervention: Video observation and PETTLEP mental training associated with physical practice
Number of subjects: 72

Group type: COMPARATOR
Intervention: Physical practice alone
Number of subjects: 72
Study: 22363616

Group type: EXPERIMENTAL
Intervention: 12 kcal kg(‐1)⋅week(‐1) for 6 months at 50% VO2peak
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: 8 kcal kg(‐1)⋅week(‐1) for 6 months at 50% VO2peak
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: 4 kcal kg(‐1)⋅week(‐1) for 6 months at 50% VO2peak
Number of subjects: 390

Group type: COMPARATOR
Intervention: Control group (non-exercise)
Number of subjects: 390
Study: 20048184

Group type: EXPERIMENTAL
Intervention: 3 MU IFNalpha2a three times a week subcutaneously for 18 months (arm A)
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: 3 MU IFNalpha2a three times a week subcutaneously for 60 months (arm B)
Number of subjects: 850
Study: 18843118

Group type: EXPERIMENTAL
Intervention: GAD-alum (20 microg, subcutaneous injections on study days 1 and 30)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (alum alone, subcutaneous injections on study days 1 and 30)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: GAD-alum
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 15879919

Group type: EXPERIMENTAL
Intervention: Isoflavone treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 60
Study: 11918110

Group type: EXPERIMENTAL
Intervention: Computer assisted learning
Number of subjects: 8

Group type: COMPARATOR
Intervention: Book based learning
Number of subjects: 8
Study: 10348471

Group type: EXPERIMENTAL
Intervention: Single dose of 12.5 mg clozapine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Chronic clozapine treatment (39+/‐9 mg up to 50 mg) for 15.8+/‐7.7 months
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15